High Court Leaves FLSA Status Of Drug Reps Up In Air

Law360, New York (February 28, 2011, 1:31 PM EST) -- The U.S. Supreme Court's decision Monday not to hear Novartis Pharmaceuticals Corp.'s bid to overturn a ruling that drug sales representatives are not exempt from overtime pay laws keeps in place a circuit court split that leaves drug companies uncertain how to proceed, attorneys say.

The high court denied petitions for certiorari filed by Novartis and Schering Corp. that aimed to overturn the U.S. Court of Appeals for the Second Circuit's ruling that they had failed to prove their sales representatives fell within exemptions to the...
To view the full article, register now.